LFCR FY 2021 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$101M-37.0% YoY

Gross Profit

$39M38.6% margin

Operating Income

-$9M-8.7% margin

Net Income

-$32M-32.0% margin

EPS (Diluted)

$-1.12

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$503M

Total Liabilities

$300M

Stockholders' Equity

$203M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$101M	$160M	-37.0%
Gross Profit	$39M	$39M	-1.1%
Operating Income	-$9M	-$26M	+65.9%
Net Income	-$32M	-$38M	+15.4%